FI962020A0 - Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina - Google Patents
Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineinaInfo
- Publication number
- FI962020A0 FI962020A0 FI962020A FI962020A FI962020A0 FI 962020 A0 FI962020 A0 FI 962020A0 FI 962020 A FI962020 A FI 962020A FI 962020 A FI962020 A FI 962020A FI 962020 A0 FI962020 A0 FI 962020A0
- Authority
- FI
- Finland
- Prior art keywords
- protease inhibitors
- pyrone derivatives
- antiviral agents
- pyrones
- present
- Prior art date
Links
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical class O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 abstract 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15502893A | 1993-11-19 | 1993-11-19 | |
| US08/319,769 US6005103A (en) | 1993-11-19 | 1994-10-12 | Pyrone derivatives as protease inhibitors and antiviral agents |
| PCT/US1994/012257 WO1995014013A1 (en) | 1993-11-19 | 1994-10-26 | Pyrone derivatives as protease inhibitors and antiviral agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI962020A0 true FI962020A0 (fi) | 1996-05-13 |
| FI962020L FI962020L (fi) | 1996-05-31 |
Family
ID=26851949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI962020A FI962020L (fi) | 1993-11-19 | 1996-05-13 | Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0729465B1 (fi) |
| JP (1) | JPH09505293A (fi) |
| AT (1) | ATE231502T1 (fi) |
| AU (1) | AU687465B2 (fi) |
| CA (1) | CA2176044A1 (fi) |
| DE (1) | DE69432056T2 (fi) |
| DK (1) | DK0729465T3 (fi) |
| ES (1) | ES2191035T3 (fi) |
| FI (1) | FI962020L (fi) |
| HR (1) | HRP940939B1 (fi) |
| HU (1) | HUT77719A (fi) |
| IL (1) | IL111672A0 (fi) |
| NO (1) | NO315747B1 (fi) |
| NZ (1) | NZ275325A (fi) |
| PT (1) | PT729465E (fi) |
| WO (1) | WO1995014013A1 (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4082724B2 (ja) * | 1995-06-28 | 2008-04-30 | バイエル・アクチエンゲゼルシヤフト | 有害生物防除剤及び除草剤として使用される２，４，５−三置換されたフェニルケト−エノール |
| DE10016544A1 (de) | 2000-04-03 | 2001-10-11 | Bayer Ag | C2-phenylsubstituierte Ketoenole |
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| CA2551602C (en) | 2003-12-26 | 2013-03-26 | Masatoshi Hagiwara | Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| CN114075161B (zh) * | 2020-08-21 | 2023-01-31 | 扬州大学附属医院 | 一种用于治疗呼吸道疾病的α-吡喃酮类化合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3277088A (en) * | 1963-10-03 | 1966-10-04 | Eastman Kodak Co | 4-(tertiaryamino)-2h-pyran-2-ones |
| FR3724M (fr) * | 1963-12-04 | 1965-12-06 | Marcel Perrault | Médicament a base d'anisoyl-3 hydroxy-4 p. méthoxy-phényl-6α-pyrone. |
| DE4308451A1 (de) * | 1992-09-10 | 1994-04-14 | Bayer Ag | 3-Aryl-pyron-Derivate |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
-
1994
- 1994-10-26 PT PT94932042T patent/PT729465E/pt unknown
- 1994-10-26 HU HU9601350A patent/HUT77719A/hu unknown
- 1994-10-26 NZ NZ275325A patent/NZ275325A/xx unknown
- 1994-10-26 AU AU80911/94A patent/AU687465B2/en not_active Ceased
- 1994-10-26 EP EP94932042A patent/EP0729465B1/en not_active Expired - Lifetime
- 1994-10-26 AT AT94932042T patent/ATE231502T1/de not_active IP Right Cessation
- 1994-10-26 DK DK94932042T patent/DK0729465T3/da active
- 1994-10-26 WO PCT/US1994/012257 patent/WO1995014013A1/en active IP Right Grant
- 1994-10-26 DE DE69432056T patent/DE69432056T2/de not_active Expired - Fee Related
- 1994-10-26 CA CA002176044A patent/CA2176044A1/en not_active Abandoned
- 1994-10-26 ES ES94932042T patent/ES2191035T3/es not_active Expired - Lifetime
- 1994-10-26 JP JP7514457A patent/JPH09505293A/ja active Pending
- 1994-11-17 IL IL11167294A patent/IL111672A0/xx unknown
- 1994-11-18 HR HR940939A patent/HRP940939B1/xx not_active IP Right Cessation
-
1996
- 1996-05-13 FI FI962020A patent/FI962020L/fi unknown
- 1996-05-15 NO NO19962016A patent/NO315747B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT77719A (hu) | 1998-07-28 |
| HRP940939A2 (en) | 1997-06-30 |
| AU8091194A (en) | 1995-06-06 |
| CA2176044A1 (en) | 1995-05-26 |
| FI962020L (fi) | 1996-05-31 |
| JPH09505293A (ja) | 1997-05-27 |
| NO315747B1 (no) | 2003-10-20 |
| NO962016D0 (no) | 1996-05-15 |
| DE69432056T2 (de) | 2003-10-09 |
| EP0729465A1 (en) | 1996-09-04 |
| DK0729465T3 (da) | 2003-04-22 |
| HRP940939B1 (en) | 2004-08-31 |
| ATE231502T1 (de) | 2003-02-15 |
| ES2191035T3 (es) | 2003-09-01 |
| NO962016L (no) | 1996-05-15 |
| PT729465E (pt) | 2003-06-30 |
| EP0729465B1 (en) | 2003-01-22 |
| IL111672A0 (en) | 1995-01-24 |
| AU687465B2 (en) | 1998-02-26 |
| HU9601350D0 (en) | 1996-07-29 |
| NZ275325A (en) | 1999-08-30 |
| DE69432056D1 (de) | 2003-02-27 |
| WO1995014013A1 (en) | 1995-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962022A0 (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| MD960171A (ro) | Derivaţi ai pironei folosiţi ca inhibitori ai proteazei şi agenţi antivirali | |
| FI962021A0 (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| MY138860A (en) | Hiv protease inhibitors. | |
| ATE196288T1 (de) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
| FI962020A0 (fi) | Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| WO1995014014A3 (en) | Pyrone derivatives as protease inhibitors and antiviral agents |